(APVO) |
| 0 (0%) 04-14 10:46 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 5.90 |
| Resistance 1: | 5.10 |
| Pivot price: | 4.34 |
| Support 1: | 3.81 |
| Support 2: | 3.17 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -87.270 |
| Book Value | 22.670 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.221 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -79.2 |
| Return on Equity (ttm) | -242.7 |
Company news
Fri, 10 Apr 2026
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why - Yahoo Finance
Thu, 09 Apr 2026
Aptevo Therapeutics (APVO) Raised to Buy: Discover the Reasons - Bitget
Thu, 09 Apr 2026
APVO Forecast, Price Target & Analyst Ratings | APTEVO THERAPEUTICS INC (NASDAQ:APVO) - ChartMill
Thu, 19 Mar 2026
Aptevo sends incoming CEO to Roth, spotlights trispecific drugs in Lisbon - Stock Titan
Fri, 13 Feb 2026
APVO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fri, 09 Jan 2026
Biotech lines up $60M to keep next-wave cancer drugs moving to 2029 - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
